Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

(2010) Michael S Ominsky et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women

(2010) Faryal S. Mirza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

PTH and PTHrP signaling in osteoblasts

(2009) Nabanita S. Datta et al.   CELLULAR SIGNALLING

Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice

(2009) Ina Kramer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Primary hyperparathyroidism and the skeleton

(2008) Leif Mosekilde   CLINICAL ENDOCRINOLOGY

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes

(2008) Charles A. O'Brien et al.   PLoS One